{"id":"https://openalex.org/W2909018341","doi":"https://doi.org/10.1182/blood-2018-99-119950","title":"Somatic Mutations in Therapy-Related Myeloid Neoplasms Are Influenced By Therapeutic Modality and Clonal Hematopoiesis of Indeterminate Potential","display_name":"Somatic Mutations in Therapy-Related Myeloid Neoplasms Are Influenced By Therapeutic Modality and Clonal Hematopoiesis of Indeterminate Potential","publication_year":2018,"publication_date":"2018-11-29","ids":{"openalex":"https://openalex.org/W2909018341","doi":"https://doi.org/10.1182/blood-2018-99-119950","mag":"2909018341"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2018-99-119950","doi":"https://doi.org/10.1182/blood-2018-99-119950","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-119950","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059910743","display_name":"Teodora Kuzmanovic","orcid":"https://orcid.org/0000-0003-2194-293X","observed_orcids":["https://orcid.org/0000-0003-2194-293X"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Teodora Kuzmanovic","raw_affiliation_strings":["Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114429797","display_name":"Bhumika J. Patel","orcid":"https://orcid.org/0009-0008-4984-7751","observed_orcids":["https://orcid.org/0009-0008-4984-7751"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bhumika J. Patel","raw_affiliation_strings":["Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047181107","display_name":"Srinivasa Reddy Sanikommu","orcid":"https://orcid.org/0000-0002-9681-0483","observed_orcids":["https://orcid.org/0000-0002-9681-0483"]},"institutions":[{"id":"https://openalex.org/I1334069289","display_name":"Carolinas Healthcare System","ror":"https://ror.org/0594s0e67","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289"]},{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Srinivasa Reddy Sanikommu","raw_affiliation_strings":["Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Carolinas Healthcare System, Charlotte, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Carolinas Healthcare System, Charlotte, NC","institution_ids":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015705148","display_name":"Yasunobu Nagata","orcid":"https://orcid.org/0000-0002-0866-929X","observed_orcids":["https://orcid.org/0000-0002-0866-929X"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Yasunobu Nagata","raw_affiliation_strings":["Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009774551","display_name":"Hassan K. Awada","orcid":"https://orcid.org/0000-0003-4268-0756","observed_orcids":["https://orcid.org/0000-0003-4268-0756"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hassan Awada","raw_affiliation_strings":["Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Fairview Park, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Fairview Park, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112104644","display_name":"Cassandra M. Hirsch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Cassandra M. Hirsch","raw_affiliation_strings":["Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022299669","display_name":"Bartlomiej P. Przychodzen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Bartlomiej P. Przychodzen","raw_affiliation_strings":["Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090717354","display_name":"Remco Jurriaan Molenaar","orcid":"https://orcid.org/0000-0001-5651-3997","observed_orcids":["https://orcid.org/0000-0001-5651-3997"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]}],"countries":["NL","US"],"is_corresponding":true,"raw_author_name":"Remco J Molenaar","raw_affiliation_strings":["Academic Medical Center, Amsterdam, Netherlands","Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Academic Medical Center, Amsterdam, Netherlands","institution_ids":["https://openalex.org/I2802928900"]},{"raw_affiliation_string":"Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057121925","display_name":"Babal Kant Jha","orcid":"https://orcid.org/0000-0002-7660-5255","observed_orcids":["https://orcid.org/0000-0002-7660-5255"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Babal K. Jha","raw_affiliation_strings":["Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102826236","display_name":"Sudipto Mukherjee","orcid":"https://orcid.org/0000-0002-8325-2603","observed_orcids":["https://orcid.org/0000-0002-8325-2603","https://orcid.org/0009-0002-0717-6319"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sudipto Mukherjee","raw_affiliation_strings":["Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082944296","display_name":"Anjali S. Advani","orcid":"https://orcid.org/0000-0003-0015-5902","observed_orcids":["https://orcid.org/0000-0003-0015-5902"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anjali S. Advani","raw_affiliation_strings":["Taussig Cancer Institute, Cleveland Clinic, Leukemia Program, Department of Hematology and Medical Oncology, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Cleveland Clinic, Leukemia Program, Department of Hematology and Medical Oncology, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086233229","display_name":"Aziz Nazha","orcid":"https://orcid.org/0000-0002-6695-7994","observed_orcids":["https://orcid.org/0000-0002-6695-7994"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aziz Nazha","raw_affiliation_strings":["Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023728016","display_name":"Aaron Thomas Gerds","orcid":"https://orcid.org/0000-0002-3422-1309","observed_orcids":["https://orcid.org/0000-0002-3422-1309"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron T. Gerds","raw_affiliation_strings":["Cleveland Clinic Taussig Cancer Institute, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic Taussig Cancer Institute, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016810759","display_name":"Hetty E. Carraway","orcid":"https://orcid.org/0000-0001-5241-3614","observed_orcids":["https://orcid.org/0000-0001-5241-3614"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hetty E. Carraway","raw_affiliation_strings":["Taussig Cancer Institute, Cleveland Clinic, Department of Hematology and Medical Oncology, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Cleveland Clinic, Department of Hematology and Medical Oncology, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055740968","display_name":"Mikkael Aaron Sekeres","orcid":"https://orcid.org/0000-0003-2009-6524","observed_orcids":["https://orcid.org/0000-0003-2009-6524"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mikkael A. Sekeres","raw_affiliation_strings":["Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085974329","display_name":"Jaroslaw Pawel Maciejewski","orcid":"https://orcid.org/0000-0002-6837-4346","observed_orcids":["https://orcid.org/0000-0002-6837-4346"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jaroslaw P. Maciejewski","raw_affiliation_strings":["Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH","Leukemia Program, Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]},{"raw_affiliation_string":"Leukemia Program, Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063314967","display_name":"Tomas Radivoyevitch","orcid":"https://orcid.org/0000-0002-9701-1851","observed_orcids":["https://orcid.org/0000-0002-9701-1851"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Tomas Radivoyevitch","raw_affiliation_strings":["Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH","Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]},{"raw_affiliation_string":"Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5015705148","https://openalex.org/A5022299669","https://openalex.org/A5057121925","https://openalex.org/A5059910743","https://openalex.org/A5063314967","https://openalex.org/A5090717354","https://openalex.org/A5112104644"],"corresponding_institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I2802928900"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"132","issue":"Supplement 1","first_page":"3084","last_page":"3084"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14078","display_name":"Multiple and Secondary Primary Cancers","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/somatic-mutations","display_name":"somatic mutations","score":0.8510000109672546},{"id":"https://openalex.org/keywords/clonal-hematopoiesis-of-indeterminate-potential","display_name":"clonal hematopoiesis of indeterminate potential","score":0.996999979019165},{"id":"https://openalex.org/keywords/secondary-myelodysplastic-syndrome","display_name":"secondary myelodysplastic syndrome","score":0.7590000033378601},{"id":"https://openalex.org/keywords/secondary-acute-myeloid-leukemia","display_name":"secondary acute myeloid leukemia","score":0.9629999995231628},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"chemotherapy","score":0.35199999809265137},{"id":"https://openalex.org/keywords/radiotherapy","display_name":"radiotherapy","score":0.8330000042915344},{"id":"https://openalex.org/keywords/complex-cytogenetics","display_name":"complex cytogenetics","score":0.5879999995231628},{"id":"https://openalex.org/keywords/chromosome-7","display_name":"chromosome 7","score":0.5400000214576721},{"id":"https://openalex.org/keywords/germline-predisposition","display_name":"germline predisposition","score":0.6110000014305115}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6119484901428223},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.6058377623558044},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.5456801056861877},{"id":"https://openalex.org/C100853524","wikidata":"https://www.wikidata.org/wiki/Q1422324","display_name":"Telecommunications Management Network","level":5,"score":0.47112414240837097},{"id":"https://openalex.org/C134305767","wikidata":"https://www.wikidata.org/wiki/Q725508","display_name":"Somatic cell","level":3,"score":0.46774154901504517},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4169501066207886},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.40532827377319336},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.38798922300338745},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3560352921485901},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.26534247398376465},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.21197623014450073},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1643858253955841},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.13422280550003052},{"id":"https://openalex.org/C165537544","wikidata":"https://www.wikidata.org/wiki/Q1327726","display_name":"Element management system","level":4,"score":0.0},{"id":"https://openalex.org/C16986412","wikidata":"https://www.wikidata.org/wiki/Q918419","display_name":"Network management station","level":3,"score":0.0},{"id":"https://openalex.org/C38652104","wikidata":"https://www.wikidata.org/wiki/Q3510521","display_name":"Computer security","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C193415008","wikidata":"https://www.wikidata.org/wiki/Q639681","display_name":"Network architecture","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2018-99-119950","doi":"https://doi.org/10.1182/blood-2018-99-119950","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-119950","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2479868281","https://openalex.org/W3154879798","https://openalex.org/W4400841013","https://openalex.org/W2910972501","https://openalex.org/W2889540601","https://openalex.org/W3137512045","https://openalex.org/W7218133402","https://openalex.org/W4387099422","https://openalex.org/W2571242012","https://openalex.org/W2792120975"],"abstract_inverted_index":{"Abstract":[0],"Treatment-associated":[1],"myeloid":[2],"neoplasias":[3],"(tMN)":[4],"are":[5,44,80,499,626],"serious":[6],"iatrogenic":[7],"complications":[8],"of":[9,25,73,87,90,118,137,152,168,175,183,191,391,430,437,441,443,449,454,464,473,479,495,581,601,608,624,679,694,709,727,738,749,760,774,796],"cytotoxic":[10],"therapies":[11,43,629],"applied":[12],"to":[13,38,55,116,145,241,460,471,650],"primary":[14,50,192],"malignancies":[15],"(PM).":[16],"With":[17,84],"increased":[18],"therapeutic":[19],"success":[20],"rates":[21],"and":[22,77,127,189,204,262,291,296,339,361,370,385,486,525,558],"prolonged":[23],"survival":[24],"cancer":[26,108],"patients,":[27,170],"tMN":[28,34,46,63,120,146,179,223,268,302,321,348,383,408,416,438,549,562,572,596,616,625],"may":[29,47,65,121,147,603],"become":[30],"more":[31,226],"prevalent.":[32],"Although":[33],"diagnosis":[35],"is":[36,95,644],"trivial":[37],"the":[39,85,98,138,428,434,579],"extent":[40],"that":[41,111,220,427,498,599],"previous":[42],"known,":[45],"represent":[48],"coincidental":[49],"MDS/AML":[51,271],"not":[52,515,619],"causally":[53],"linked":[54],"chemotherapy":[56],"(ctx)":[57],"or":[58,110,113,133,185,519,681,696,711,729,740,751,762,776,798],"radiation":[59],"(rtx).":[60],"Other":[61],"seemingly":[62],"cases":[64,174,349,365,411,586],"carry":[66],"germ":[67,640],"line":[68,641],"predisposition":[69,642],"responsible":[70],"for":[71,187,419,578,631,639,647],"co-occurrence":[72],"2":[74,423],"neoplastic":[75],"processes,":[76],"finally":[78],"others":[79],"truly":[81],"treatment-related":[82],"MN.":[83],"recognition":[86],"clonal":[88,480],"hematopoiesis":[89],"indeterminate":[91],"potential":[92],"(CHIP),":[93],"it":[94],"also":[96,122,575],"likely":[97],"preexisting":[99],"CHIP":[100,456,524,609],"would":[101],"be":[102,130,148,604],"either":[103,131],"selected":[104],"for,":[105],"eliminated":[106],"by":[107,150,209,477,628],"therapies,":[109],"ctx":[112,186,357,369],"rtx":[114,184,345,371,373],"lead":[115],"emergence":[117],"CHIP.":[119,636],"manifest":[123],"without":[124],"antecedent":[125],"CHIP,":[126],"thus":[128],"could":[129],"CHIP-derived":[132,500,529,561,585,612],"de":[134,509,542,556,570,594,614],"novo.":[135],"Some":[136],"problems":[139],"in":[140,283,294,301,312,320,337,344,398,406,421,439,488,502,506,513,517,522,610],"assigning":[141],"somatic":[142,218],"mutational":[143],"pattern":[144],"alleviated":[149],"application":[151],"proper":[153],"control":[154],"groups":[155,286],"which":[156,366],"include":[157],"sMN":[158,244,254,276,305],"(MN":[159],"after":[160],"PM":[161,240,582,602,632],"treated":[162],"only":[163,342],"surgically).":[164],"In":[165,382],"our":[166,489],"cohort":[167],"1058":[169],"we":[171,216],"identified":[172],"109":[173],"such":[176],"sMN,":[177,201],"266":[178],"with":[180,356,364,606],"a":[181,388],"history":[182],"PM,":[188],"683":[190,205],"MN":[193,242,511],"(pMN),":[194],"having":[195],"no":[196],"PM.":[197],"Of":[198],"these":[199,212,648],"65":[200],"145":[202],"tMN,":[203],"pMN":[206,399],"were":[207,269,287,298,316,341,354,412,417,469,531,541],"sequenced":[208],"NGS.":[210],"Using":[211,545],"three":[213],"patient":[214],"groups,":[215],"sought":[217],"mutations":[219,282,353,444,450],"distinguish":[221],"them.":[222],"presented":[224],"as":[225,445,447,552,633,635],"aggressive":[227],"disease:":[228],"diagnosed":[229],"older":[230,568,592],"vs.":[231,243,246,252,272,303,322,346,372,395,409,613],"pMN/sMN":[232,323,410],"(68":[233],"years,":[234,248],"p<.001)":[235],",":[236],"shorter":[237],"latency":[238],"from":[239,508],"(8.7":[245],"10.5":[247],"p=.085),":[249],"complex":[250],"cytogenetics":[251],"pMN,":[253,274,304],"(p=1.4x10-5,":[255],"p=2.7x10-4)":[256],"including":[257],"chromosome":[258],"7":[259],"(p=1.7x10-7,":[260],"p=8.4x10-5)":[261],"5":[263],"abnormalities":[264],"(p=.044,":[265],"p=.09),":[266],"50%":[267],"advanced":[270],"35%":[273],"42%":[275],"(p=.00016,":[277],"p=.25).":[278],"The":[279,403,621],"most":[280,317],"common":[281,300,380],"all":[284],"3":[285,493],"TET2,":[288,532],"DNMT3A,":[289,533],"ASXL1":[290],"SRSF2.":[292],"Mutations":[293,336],"SF3B1":[295],"JAK2":[297,534],"less":[299],"(p=.058,":[306],"p=.014;":[307],"p=.011,":[308,329],"p=.327)":[309],"while":[310,414,535],"those":[311,396,472,497,520],"TP53,":[313],"KIT,":[314],"EZH2,WT1":[315],"frequently":[318],"mutated":[319,405],"(OR":[324,358],"2.6,":[325],"p=.002,":[326],"OR":[327,330,333],"6,":[328],"1.9,":[331],"p=.083,":[332],"3.2,":[334],"p=.08).":[335],"ETV6":[338],"EZH2":[340],"found":[343,397,521],"ctx-treated":[347],"(p=.046,":[350],"p=.004).":[351],"TP53":[352,375,384,407],"associated":[355],"7.2,":[359],"p=0.062),":[360],"when":[362],"combined":[363],"received":[367],"both":[368,523],"alone,":[374],"mutation":[376],"was":[377,379,393,458],"9.3x":[378],"(p=.014).":[381],"EZH2-mutated":[386,415],"cases,":[387],"higher":[389],"proportion":[390],"transversions":[392],"observed":[394],"(p=.055,":[400],"p=":[401],"0.052).":[402],"domains":[404],"similar,":[413],"enriched":[418],"hits":[420,530],"domain":[422],"(p=0.0604).":[424],"This":[425,491,574],"suggests":[426],"type":[429],"treatment":[431],"utilized":[432,630],"influences":[433],"molecular":[435,622,654],"signature":[436],"terms":[440],"frequency":[442,485,505],"well":[446,634],"types":[448],"found.":[451],"A":[452],"meta-analysis":[453],"9":[455],"studies":[457],"performed":[459],"pool":[461],"overall":[462],"frequencies":[463,468],"MN-related":[465],"genes.":[466],"These":[467],"compared":[470],"ancestral":[474,504],"events":[475],"(determined":[476],"recapitulation":[478],"hierarchy":[481],"via":[482],"variant":[483],"allele":[484],"zygosity)":[487],"cohort.":[490],"yielded":[492],"categories":[494],"mutations:":[496],"(frequency":[501],"CHIP>":[503],"MN),":[507],"novo":[510,543,571,595,615],"(mutations":[512],"gene":[514],"seen":[516],"CHIP),":[518],"MN,":[526],"termed":[527],"mix-derived.":[528,560],"STAG2,":[536],"EZH2,":[537],"APC,":[538],"MLL,":[539],"WT1":[540],"hits.":[544],"this":[546],"categorization":[547],"scheme":[548],"break":[550],"down":[551],"19%":[553],"CHIP-derived,":[554],"38%":[555],"novo,":[557],"24%":[559],"were,":[563,587],"on":[564,588,675,690,705,723,734,745,756,770,792],"average,":[565,589],"6":[566],"years":[567,591],"than":[569,593],"(p=.019).":[573],"held":[576],"true":[577],"age":[580,600],"diagnosis,":[583],"where":[584],"10":[590],"(p=.0175),":[597],"suggesting":[598],"correlated":[605],"acquisition":[607],"tMN.":[611],"latencies":[617],"did":[618],"differ.":[620],"signatures":[623],"influenced":[627],"Targeted":[637],"sequencing":[638],"genes":[643],"under":[645],"way":[646],"patients":[649],"further":[651],"characterize":[652],"their":[653],"profiles.":[655],"Disclosures":[656],"Nazha:":[657],"MEI:":[658],"Consultancy.":[659,669,810],"Gerds:Apexx":[660],"Oncology:":[661],"Consultancy;":[662,664,666,687,783,786,806],"Incyte:":[663],"Celgene:":[665,688,732],"CTI":[667],"Biopharma:":[668],"Carraway:Jazz:":[670],"Speakers":[671,684,701,715,719,779,801],"Bureau;":[672,685,702,716,780,802],"Balaxa:":[673],"Membership":[674,689,704,722,733,744,755,769,791],"an":[676,691,706,724,735,746,757,771,793],"entity's":[677,692,707,725,736,747,758,772,794],"Board":[678,693,708,726,737,748,759,773,795],"Directors":[680,695,710,728,739,750,761,775,797],"advisory":[682,697,712,730,741,752,763,777,799],"committees,":[683,698,778,800],"FibroGen:":[686],"Research":[699],"Funding,":[700],"Amgen:":[703],"committees;":[713,731,742,753],"Novartis:":[714],"Agios:":[717],"Consultancy,":[718,768,790],"Bureau.":[720],"Sekeres:Celgene:":[721],"Opsona:":[743,754],"committees.":[764],"Maciejewski:Alexion":[765],"Pharmaceuticals,":[766,788,804,808],"Inc.:":[767,789],"Apellis":[781,784],"Pharmaceuticals:":[782,785],"Alexion":[787],"Ra":[803,807],"Inc:":[805,809]},"counts_by_year":[{"year":2019,"cited_by_count":1}],"updated_date":"2026-09-24T07:57:37.273135","created_date":"2019-01-25T00:00:00"}